News for Intellipharmaceutics International Inc. (IPCIF)

MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED AUGUST 31, 2023 The...

MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS For the THREE MONTHS ENDED February 28, 2023 The following...

Read Contrasting NRx Pharmaceuticals (NASDAQ:NRXP) and Intellipharmaceutics International (OTCMKTS:IPCIF) at ETF Daily News

Read Analyzing Intellipharmaceutics International (OTCMKTS:IPCIF) & Biora Therapeutics (NASDAQ:BIOR) at ETF Daily News

Read Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Sees Large Drop in Short Interest at ETF Daily News

TORONTO (AP) _ Intellipharmaceutics International Inc. (IPCIF) on Thursday reported a loss of $841,000 in its fiscal second quarter.On a per-share basis, the To...

Read Arcutis Biotherapeutics (NASDAQ:ARQT) vs. Intellipharmaceutics International (OTCMKTS:IPCIF) Head to Head Analysis at ETF Daily News

Read Short Interest in Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Increases By 720.0% at ETF Daily News

Read Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Short Interest Down 28.6% in May at ETF Daily News